Universal Oral Vaccine: The Immune Milk Saga!

Part IV: The Proper Way to Obtain Effective Colostrum

by Anthony di Fabio

Doctors who treat tuberculosis patients are very aware of antibiotic-resistant tubercule mycoplasms on the rise. They could well consider for this and other diseases or allergies, requesting the FDA’s permission to ruII a double-blind study using specially prepared colostrum.

“Double-blind” means that neither the patient nor the doctor will know which one is receiving the presumably active ingredient, and which one is receiving the placebo, the inactive ingredient, until the study is completely run and ready for analysis.

Here’s what’s involved:

1. The doctor must prepare a research plan of action, a study proposal.

2. The study proposal, with all attached research references, must be submitted to an Institutional Review Board for review and approval. Usually, but not always, the Institutional Review Board is attached to a medical school.

3. If the study raises objections, it must be modified. When approved, it is then submitted to the FDA, spelling out exactly what’s to be done, how the research is to be evaluated, and how the product is to be tested and how the placebo product will be prepared, labelled and used.

4. If approved by the FDA, the study is given an IND number, which means “Investigate New Drug number.”

5. The study is then carried out, and final reports written for FDA review as well as for publication, if possible.

This sounds like a simple, straight-forward procedure, but, considering the danger that is posed to the pharmaceutical industry, where specially prepared cow’s colostrum is potentially effectively producing cures while much touted and damaging pharmaceuticals are not, there will be many pitfalls placed between the honest doctor and final permission.

It is also a very expensive process, but probably would be nowhere near the expense of bringing in a new and unknown drug – providing the FDA plays square.

When Herbert Struss, PhD, obtained permission from the FDA to use these products on rheumatic fever, rheumatoid arthritis, multiple sclerosis and allergies in the early ’60s, progress in patient wellness was quite obvious at different medical centers.

Dr. Struss was visited by FDA officials who, without adequate explanation, ordered him to cease and desist. He refused, explaining that their agency had granted him an IND – permission to conduct clinical studies.

His next FDA visitors were from higher up administrators who warned him that if he didn’t stop his studies, they’d put him in jail.

Having children and a wife to support, Dr. Struss bowed to governmental suppression, and did no further work on this amazing healing product throughout the remainder of his life.

Perhaps the intervening 30 or so years have mellowed the FDA! Growing influence of the new Center for Complementary and Alternative Medicine under the National Institutes of Health will provide an umbrella for submission of studies of immune milk on humans. Also, many prestigious mepical schools are rapidly installing complementary/alternative medicine courses and/or departments, and these are beginning to have influence on the politics of what should or should not be scientifically studied.

A Homeopathic Approach

Exempted from FDA surveillance are standardized homeopathic remedies.

The preparation of these homeopathic remedies is begun by using the colostrum from specially prepared allergens or antigens as a “mother.”

A “mother” is the initial brew or dissolved substance that is that “active ingredient” used to make homeopathic remedies. A 1X homeopathic remedy is 1 volume of mother to 9 parts of distilled water; 2X is 1 volume of the 1X solution to 9 parts of water (or 1 of the mother to 99 of water), 3X is 1 volume of 2X solution to 9 parts of water (or 1 of mother to 999 parts of water) and so on, until the mother has been diluted 1 part mother to 999,999 parts of water to achieve a 6X dilution.

Homeopathic remedies are prepared by and can be purchased from Beaumont Bio-Med, P.O. Box 6, Waukon, Iowa 52172. Ingredients for ‘’rheumatism” for example, includes Rhus tox (poison ivy) 12X, Causticum (potassium hydrate) 12X, Lac vaccinum (cow’s milk) 30X, in a base of lactose, 20% alcohol and distilled water. A 2 fluid ounce bottle lasts about 2 months. Properly prepared colostrum, of course, is the basis for the “cow’s milk” ingredient. The milk products used are defined in the Homeopathic Pharmacopoeia of the United States.

Additional homeopathic remedies prepared in the same manner include preparations made from specific microorganisms for cold and flu, sore throat, fever and inflammation, stomach ache, skin, acne and muscle and joint pain. Among those patents filed and dated from 1945 to 1992 are found some exemplary studies related to animals, using homeopathic remedies.

Groups of four mouse test subjects, using deadily Pseudomonas aurogenosa challenges were conducted using test categories of water, colostrum and milk as the raw materials. A first “mother” prepared from the first cow’s colostrum and also used to produce a second mother by passing the first mother’s colostrum into the cistern of a second cow, after which homeopathic remedies were prepared from the second mother derived from the second cow at 3X and 6X potencies.

In the first table described in the patent, mouse survival was higher for 6X than for 3X for both colostrum and milk mother sources, but surprisingly, even higher results were obtained when both the 3X or 6X potency quantities administered were cut by one half or one quarter in both colostrum and milk, resulting in nearly 100% mouse survival rate, in most cases! This surprises me, but would not have surprised Hahneman, founder of homeopathy who stated two principles: (1) the more dilute, the stronger the homeopathic effects; (2) the less used, the stronger the effects.

A second study (replicated) gave similar results.

One hundred and thirty cows having udder congestion and/or abnormal milk contributed milk samples. Staphylococcus aureus, a Streptoccusagalactiae, g-Streptococcus agalactiae, and E. Coli were collected and used to make a first homeopathic mother from a healthy cow.

Homeopathic material was prepared to the 6X potency, whence these were bottled under 50 ml sterile conditions, of which ten 50 cc bottles were sent to the veterinarian.

“Each month the cows in a herd having high cell counts (disease indicator) are listed on the owners required report (DH1A) for treatment. The high [bacteria] cell count cows in the herd were treated with 2-4 cc (ml) doses of the homeopathic product orally in their feed at twelve-hour intervals with the results shown in the third table in the patent.”36g

In the third table, results showed that in most cases, a High Somatic Cell Count (SCC) of greater than 1,000,000 reduced to less than 200,000 within two weeks of treatment.

A similar study was performed, with similar results, using the cow’s colostrum instead of milk.

Quantum Research Inc. has also developed homeopathic remedies. Through Matol Botanical International, Ltd, [1111, 46e Avenue, Lachine (Quebec) Canada, H8T 3CS] a Bioimmune OSF™ Express nasal spray product can be obtained “for acute symptoms associated with the common cold, influenza, sinusitis, otitis media and other similar conditions.” It’s active ingredients include silica 22X, silver nitrate 21X, belladonna ex. herbal 15X. It’s inert ingreditns are “filtered water, proprietary extract of whey permeate, 2-deoxy-d-glucose, eucalyptus oil, benzalkonium chloride and therimosal (as preservatives), disodium EDTA (as stabilizer), sodium hydroxide.)

The Vaccination Process

Zoltan Rona, MD, in Nature’s Impact,47 says, “At one time, conventional medical doctors were enthusiastic about using colostrum as an antibiotic. This occurred prior to the introduction of sulfa drugs and penicillin. In the 1950s, before the wide-scale use of corticosteroids as anti-inflammatory agents, colostrum was used to treat rheumatoid arthritis. Dr. Albert Sabin, developer of the polio vaccine, discovered that colostrum contained antibodies against polio; he recommended it for children susceptible to catching the disease. For thousands of years, Ayurvedic physicians have used bovine colostrum for medicinal purposes.”

When vaccination against microorganisms or pollens takes place, antigens or allergens are introduced into the human body. The object is to induce the body to produce vast quantities of antibodies which, presumably, result in (memory cell) protection against antigens or allergens.

According to Harold Buttram, MD and Richard Piccola, MHA, (Our Toxic World: Who is Looking After Our Kids? available from this foundation), vaccinations over-challenge small infants, depress the immune system, transfer into our bodies undesirable viruses including additional damaging contamination, disturb brain and nervous tissue, interfere with natural immunity-developing processes, bring about death disability in some, and are probably responsible chronic fatigue immune dysfunction syndrome as well as some other degenerative diseases.

If the end object of vaccination with the use of antigens and allergens is to bring about production of antibodies and cooperating complement - protective transfer-of-immunity factors (called “transfer factors”) - when under attack by the microorganism or allergen, then why not introduce the antibodies and complement and other transfer factors directly, thus saving time, energy, and health, especially that of immature immune systems, such as babies?

This grand concept makes sense only if (1) there is a cheap source for antigen-specific antibodies and complement, and (2) the developed antigen-speciific antibodies and complement are identical to that of humans. The antibodies, complement, and other transfer factors produced via other maminals, such as cows or goats, are low in cost and indeed identical to that of humans, as has been repeatedly demonstrated over more than 40 years of research.

While it is considered optimum to use raw colostrum properly prepared - the farther from raw colostrum during handling and treatment, the more opportunity to damage or weaken the disease-specific components, according to Herbert Struss, PhD - the active transfer factors can be very carefully pasteurized and freeze-dried (lyophilized). During Philip Derse’s past 30 years or so of research (Derse & Schroeder Associates), he learned that the active components can also be obtained from milk produced by specifically challenged cows, when the milk is properly processed. This discovery increases by vast amounts, the available active ingredients from specifically challenged cows, and therefore lowers cost further.

Finally, the active products can be made to go farther and lower costs even more if the active ingredients are rendered into homeopathic remedies having specificity for given microorganisms- or allergen-based diseases.

According to Fudenberg and Pizza, the FDA “approved” Bovine Transfer Factor for human use again in 1985 and bovine colostrum in 1980.

Also according to Fudenberg and Pizza, two federal courts (one a Medicare court in a suburb of Washington and the other a health and human services court in Fan Francisco) ruled in 1987 that in diseases where no presription medicine exists Transfer Factor preparations are not experimental and furthermore ruled that insurance companies must reimburse the patients for the cost of Transfer Factor preparation.25


Anthony di Fabio

The Arthritis Trust

7376 Walker Road

Fairview, Tennessee 37062 USA

Website: www.arthritistrust.org